NCT01283789 2017-02-08Lapatinib and RAD-001 for HER2 Positive Metastatic Breast CancerUniversity of Kansas Medical CenterPhase 2 Unknown23 enrolled
NCT02238509 2016-06-15Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 TherapiesConsorzio OncotechPhase 2 Unknown154 enrolled